I contend that we are in a trading range of 3,000 to 3800 on S&P - that would mean we are just going down. There really isn't good news in the market and there's going to be more downside. I think we go to 3,000 as the earnings revisions are brought down through mid July with maybe a stop at 3500. I think $SPXU, $SQQQ and $UVXY are good for swing trades. 

$DAL and $TSLA indicate to me that we are going to have a travel nightmare this weekend. 

$TSLA also at the delivery center yesterday - there was no hype and no energy. Look for it to go towards low $600's here. 

$DRV - short real estate - I like this one long too. 

$RIO - MacD Cross up - commodities have been crushed 

$DVN - above $60 so look for weakness to sell. 

$MU on earnings - I'm less hyped on it. I have a fear they will bring guidance down. 

$UCO - I like this to $55 

$CVX - Cross up

$XOM - Cross up

$OXY - be careful and look for weakness to sell 

$OAS - cross up 

$FANG - cross up

$PXD - cross up

$MPC - cross up

$QCOM - $AAPL failed at 5G chips and will have to resign the contract with $QCOM - big news 

$WEAT - I think this goes up

$GOOGL $GOOG - I like this with the $2200 level 

$GIS - not ready to buy yet, but with food shortage this will be great 

$REV - kiss of death with a CNBC update

$MPLX - cross up

$XLF - I like this 

$NVDA - I think anything in the $150 range is a great long term buy - it might dip to $140's, but this is long term 

$NKE - under $100 it's a buy with China opening

$TSLA - again - should have sold at $750 

$CLF - commodities are getting killed and if in the $15 range - I like it with earnings coming up

$TGT - love this on the 2nd half guidance at $140

$ZIM - I'm unsure of this just because of large inventories, but it's almost trading at it's fair value

$FTNT - I like this based on the value and recent split 

$ABBV - not a buy now, but you can hold it for the dividend

$SPG - under $100 - buy it 

$MRNA - without Congressional funding - stay away from it 

$FDX - first investor day in 10 years 

$ARKG - should have sold at $34 - I see weakness